Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxue Danggui Tangjiang is a traditional Chinese medicine (TCM) oral syrup manufactured by Yaodu Zhangshu Pharmaceutical, a subsidiary of Renhe Group. It is an approved herbal formulation in China designed to "nourish blood and regulate menstruation" (补血和血,调经止痛). The syrup is primarily indicated for conditions characterized by blood deficiency, such as menstrual irregularities, dysmenorrhea (menstrual pain), and general weakness or anemia-like symptoms. The formulation typically centers on *Angelica sinensis* (Danggui), a cornerstone herb in TCM for gynecological health, often combined with other traditional herbs like *Paeonia lactiflora* and *Rehmannia glutinosa* to enhance its tonifying effects. As a regulated TCM product, it is widely used in clinical practice and over-the-counter for women's health and blood replenishment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxue Danggui Tangjiang.